Suspensions fluconazole oral

Diflucan for oral suspension contains 350 or 1400 mg of fluconazole and the following inactive ingredients sucrose, sodium citrate dihydrate, citric acid anhydrous, sodium benzoate, titanium dioxide, colloidal silicon diox- 

---

There have been few controlled studies that assess the effectiveness of antifungals. Doubling of the fluconazole dosage to 400 or 800 mg/day may be effective in some patients with infection caused by Candida of intermediate resistance, although the response may be only transient. Fluconazole oral suspension may be beneficial in some patients because of increased salivary concentrations obtained when the suspension is taken with the swish-and-swaUow technique. Itraconazole oral suspension is effective in 55% to 70% of patients however, the benefit is short-lived if chronic suppressive therapy is not maintained, and there is a high likelihood of the development of itraconazole resistance. Amphotericin B oral suspension is limited primarily to use in azole-refractory patients It has broad spectrum... 

The safety profile of fluconazole has been assessed in 562 children (aged 0-17 years 323 boys and 239 girls), enrolled into 12 clinical studies of prophylactic or therapeutic fluconazole in predominantly immunocompromised patients (66). Most of the children received multiple doses of fluconazole 1-12 mg/kg, given as oral suspension or intravenously. Overall, 58 children reported 80 treatment-related adverse effects. The most common adverse effects were associated with the gastrointestinal tract (7.7%), the skin (1.2%), or the liver and biliary system (0.5% or three patients). Overall, 18 patients discontinued treatment owing to adverse effects, mainly gastrointestinal. Dosage and age did not affect the incidence and pattern of adverse effects. Treatment-related... 

In 34 otherwise healthy infants with oral candidiasis randomized to either nystatin oral suspension qds for 10 days or fluconazole suspension 3 mg/kg in a single daily dose for 7 days, 6 of 19 were cured by nystatin and all of 15 by fluconazole (67). Fluconazole was tolerated without apparent adverse events. 

The oral bioavailability of fluconazole, following administration of cither tablet or oral. suspension do.sagc forms, is excellent. Apparently, the presence of two weakly basic triazole rings in the molecule confers sufficient aqueous solubility to balance the lipophilicity of the 2.4-difluorophenyl group. The oral absorption of fluconazole, in contrast to the oral absorption of ketoconazolc or itraconazole, is not affected by alteration in ga.strointcstinal acidity or the presence of food. 

For systemic treatment of fungal infections in dogs and cats, ketoconazole and fluconazole are available as tablets and oral suspensions, itraconazole as capsules, while miconazole and fluconazole are available as parenteral solutions. Even though ketoconazole is often effective, itraconazole may be the preferred azole for the treatment of systemic disease caused by dimorphic fungi (Blastomyces dermatitidis, Histoplasma capsulatum, Sporothrix schenckii). The activity of fluconazole against dimorphic fungi is limited to coccidioidal disease (Coccidioides immitis), but this azole penetrates the blood-brain barrier. 

Fluconazole (diflucan, others) is marketed as tablets for oral administration, powder for oral suspension, and intravenous solutions containing 2 mg/mL. Dosage is 50-800 mg once daily for oral or intravenous administration. Children are treated with 3—6 mgAg once daily. 

Mucocutaneous candidiasis is generally not life-threatening nor invasive and can be treated with topical azoles (clotrimazole troches), oral azoles (fluconazole, ketoconazole, or itraconazole), or oral polyenes (such as nystatin or oral amphotericin B). Orally administered and absorbed azoles (ketoconazole, fluconazole, or itraconazole solution), amphotericin B suspension, intravenous caspofungin, or intravenous amphotericin B are recommended for refractory or recurrent infections.20... 

Itraconazole is a broad-spectrum synthetic triazole that has good oral bioavailability and is less toxic than amphotericin B and ketoconazole.The solution has better bioavailability than the capsule and provides higher plasma concentration levels. Compared with fluconazole and ketoconazole, itraconazole penetrates all ocular tissues poorly when orally administered. Itraconazole can be used as a 1% ophthalmic suspension but is not very effective in treating severe fungal keratitis. 

Candidiasis of the alimentary tract mucosa responds to amphotericin, fluconazole, ketoconazole, miconazole or nystatin as lozenges (to suck, for oral infection), gel (held in the mouth before swallowing), suspension or tablets. 

---